Access To Medicine Foundation

Often searched

Index ranking

Vacancies

10 year analysis

  • Healthcare inequity
    • How big is the problem?
    • How we drive change
    • Our story
    • Our impact
    • How big is the problem?
    • How we drive change
    • Our story
    • Our impact
  • Become a catalyst
    • Investors
    • Companies
    • Government & policymakers
    • Events & engagements
    • Investors
    • Companies
    • Government & policymakers
    • Events & engagements
  • Sectors and research
    • R&D-based pharma companies
    • Medical gas companies
    • Generic medicine manufacturers
    • Diagnostics companies
    • Vaccine manufacturers
    • Research hub
    • Company profiles & report cards
    • R&D-based pharma companies
    • Medical gas companies
    • Generic medicine manufacturers
    • Diagnostics companies
    • Vaccine manufacturers
    • Research hub
    • Company profiles & report cards
  • Cross-Sector Programmes
    • Antimicrobial resistance
    • Diabetes care
    • Antimicrobial resistance
    • Diabetes care
  • On the pulse of global health
    • Access insights
    • The Health Equity podcast
    • Access insights
    • The Health Equity podcast
  • News
  • Our team
  • Featured insights
  • Governance & financials
  • Vacancies
  • Media coverage
  • FAQ
  • Contact us

Date

12 September 2019

A dire scarcity of drugs is worsening, in part, because they are so cheap

The Economist covers the rise in drugs shortages, highlighting that the number of manufacturers, particularly for antibiotics, is growing ever smaller.

Direct links

Read the full article

In describing the impact for low- and middle-income countries, the newspaper quotes Jayasree K, Iyer, Executive Director of the Access to Medicine Foundation:

"Data from poor countries are more limited but shortfalls in America or Europe often flag up a worldwide shortage"

Jayasree describes how, when supplies are squeezed, drug firms may prioritise selling their medicines to rich countries where they can command higher prices. Some countries are considering paying more for critical older medicines in order to secure their supply, which will also help safeguard supplies for other countries.

Access to Medicine Foundation

Interested in our work?

Access to Medicine Foundation is funded by

Terms & conditions

Privacy & cookie policy

Disclaimer

Copyright 2004 - 2025 Access to Medicine Foundation - All Rights Reserved